RT Journal Article
SR Electronic
T1 Classification of Hyper-scale Multimodal Imaging Datasets
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.01.03.23284138
DO 10.1101/2023.01.03.23284138
A1 MacFadyen, Craig
A1 Duraiswamy, Ajay
A1 Harris-Birtill, David
YR 2023
UL http://medrxiv.org/content/early/2023/01/05/2023.01.03.23284138.abstract
AB Algorithms that can classify hyper-scale multi-modal datasets, comprising of millions of images, into constituent modality types can help researchers quickly retrieve and classify diagnostic imaging data, accelerating clinical outcomes. This research aims to demonstrate that a deep neural network that is trained on a hyper-scale dataset (4.5 million images) composed of heterogeneous multi-modal data, can be used to obtain significant modality classification accuracy (96%). By combining 102 medical imaging datasets, a dataset of 4.5 million images was created. A ResNet-50, ResNet-18 and VGG16 were trained to classify these images by the imaging modality used to capture them (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and X-ray) across many body locations. The classification accuracy of the models was then tested on unseen data.The best performing model achieved classification accuracy of 96% on unseen data. The model achieved a balanced accuracy of 86%.This research shows it is possible to train Deep Learning (DL) Convolutional Neural Networks (CNNs) with hyper-scale multimodal data-sets, composed of millions of images. The trained model can be used to classify images by modality, with the best performing model achieving a classification accuracy of 96%. Such models can find use in real-world applications with volumes of image data in the hyper-scale range, such as medical imaging repositories, or national healthcare institutions. Further research can expand this classification capability to include 3D-scans.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was approved by the University of St Andrews University Teaching and Research Ethics Committee (UTREC), approval code CS15171.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study comes from multiple sources, as indicated in Appendix Datasets. If not specified here then the data can be accessed with no special permission required by the data provider. Permission was required to access MURA, ChexPERT, MRNet, the NDA Osteo-Arthritis Initiative and BraTS20. Code created for this research is hosted on GitHub with an MIT Licence.